Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer’s disease

被引：0
|
作者：
Swetaleena Shaw [1 ]
Pratyush Porel [2 ]
Khadga Raj Aran [2 ]
机构：
[1] ISF College of Pharmacy,Department of Pharmacy Practice
[2] ISF College of Pharmacy,Department of Pharmacology
来源：
Molecular Biology Reports | 2025年 / 52卷 / 1期
关键词：
Transthyretin; Alzheimer’s disease; Amyloid-β; Neuroprotection; Thyroxine; Retinol;
D O I：
10.1007/s11033-025-10485-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The past, present, and future of disease-modifying therapies for Alzheimer's disease
    Suzuki, Kazushi
    Iwata, Atsushi
    Iwatsubo, Takeshi
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2017, 93 (10): : 757 - 771
  • [2] Disease-modifying therapies in Alzheimer's disease
    Salloway, Stephen
    Mintzer, Jacobo
    Weiner, Myron F.
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2008, 4 (02) : 65 - 79
  • [3] Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease
    Bateman, Randall J.
    Klunk, William E.
    NEUROTHERAPEUTICS, 2008, 5 (03) : 381 - 390
  • [4] Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease
    Randall J. Bateman
    William E. Klunk
    Neurotherapeutics, 2008, 5 : 381 - 390
  • [5] Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives
    Imbimbo, Bruno P.
    Lozupone, Madia
    Watling, Mark
    Panza, Francesco
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 919 - 933
  • [6] Novel Disease-Modifying Therapies for Alzheimer's Disease
    Jiang, Teng
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 475 - 492
  • [7] Disease-modifying therapies for Alzheimer disease
    Cummings, Jeffrey L.
    Doody, Rachelle
    Clark, Christopher
    NEUROLOGY, 2007, 69 (16) : 1622 - 1634
  • [8] Disease-Modifying Alzheimer's Disease Therapeutic Candidate
    Kelleher-Andersson, Judith
    NEUROTHERAPEUTICS, 2012, 9 (03) : 679 - 680
  • [9] Development of disease-modifying therapies against Alzheimer's disease
    Iwatsubo, Takeshi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (09) : 491 - 494
  • [10] Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
    Munoz-Torrero, D.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (24) : 2433 - 2455
12345